Skip to main content

PNH Patient Travel Assistance Fund

Aplastic Anemia and MDS International Foundation (AAMDSIF)

UnknownUnder review·Apr 24, 2026

Information regarding the PNH Patient Travel Assistance Fund is not available on this page. The page content details information about Antithymocyte Globulin, a drug used in treating bone marrow failure diseases, and provides general information about the Aplastic Anemia and MDS International Foundation.

Covers
transportationfinancial assistance
Enrollment cycle
unknown

Eligibility

The fund provides travel assistance for patients diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH). Specific eligibility criteria including income levels and distance requirements are not specified in the provided text.

Apply

Application goes directly to Aplastic Anemia and MDS International Foundation (AAMDSIF). RxCopays does not receive compensation.

Go to application →

Status source

The grant name 'PNH Patient Travel Assistance Fund' is not mentioned on this page, nor is any enrollment information.

Rare-disease support beyond financial help

This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: